Yahoo Web Search

Search results

1. • 

     How Long Do Leftovers Really Last and What Can You Do To Extend the Shelf Life?

     Health via Yahoo News· 6 days ago

     As a result, you may experience symptoms like diarrhea, vomiting, abdominal pain, fever, and...

2. • Team develops an intelligent nanodevice based on a component of cinnamon essential oil as an...

     Phys.org· 4 days ago

     It could be applied for the elimination of pathogens that may be present in food, wastewater and in the treatment of nosocomial infections, which are those acquired during hospital stays. In ...

3. • 

     MSU researchers believe a vaccine could slow down antibiotic resistance

     WOOD via Yahoo News· 2 days ago

     A team of researchers at Michigan State University believe that a vaccine could be used to prevent...

4. • WHO updates list of most dangerous drug-resistant pathogens

     Becker’s Hospital Review· 4 days ago

     For the first time in seven years, the World Health Organization has updated its list of the most dangerous, antimicrobial resistant pathogens. The revised list includes 24 pathogens from 15 ...

5. • 

     Improving infection prevention could prevent 750,000 superbug deaths a year

     Euronews via Yahoo News· 4 days ago

     A new four-part series in the Lancet details how so-called superbugs are impacting global health and...

6. • Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and...

     Centers for Disease Control and Prevention· 4 days ago

     Interrupting transmission and infection caused by multidrug-resistant organisms (MDROs) in healthcare settings can help mitigate the global antimicrobial resistance (AMR) crisis, reduce illness ...

7. • Drug Discovery, Development and Evaluation Hub Welcomes New Faculty to Fuel Innovation

     UB Reporter· 7 days ago

     The University at Buffalo School of Pharmacy and Pharmaceutical Sciences’ (UB SPPS) Drug Discovery, Development and Evaluation (DDDE) Hub, a leading research engine in the fields of pharmaceutical ...

8. • Q1 2024 Biomx Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

     As a reminder, BX211 is a personalized phage treatment being evaluated in a randomized, double-blinded, placebo-controlled, multicenter Phase 2 trial for subjects with DFO associated with < ...

9. • 

     Earnings call: BiomX reports Q1 2024 results, optimistic on phage therapies By Investing.com

     Investing.com· 7 days ago

     BiomX Inc. (NYSE: NYSE:PHGE), a biotechnology company specializing in phage-based therapies, has...